Almirall, S.A. (LBTSF)
LBTSF Stock Price Chart
Explore Almirall, S.A. interactive price chart. Choose custom timeframes to analyze LBTSF price movements and trends.
LBTSF Company Profile
Discover essential business fundamentals and corporate details for Almirall, S.A. (LBTSF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
3 Aug 2012
Employees
2.03K
Website
https://www.almirall.comCEO
Carlos Gallardo Piqué
Description
Almirall, S.A., a biopharmaceutical company, engages in the research, development, manufacture, and sale of skin-health related medicines in Europe, the United States, and internationally. The company offers its products for dermatological diseases comprising actinic keratosis, atopic dermatitis, androgenic alopecia, psoriasis, onychomycosis, oncodermatology, acne, and orphan indications, as well as for cardiovascular, musculo-skeletal, respiratory, and nervous system; alimentary tract and metabolism; antiinfectives for systemic use; genito urinary system and sex hormones; immunostimulants; and systematic hormonal preparations. Its products include Ilumetri, Solaraze, Actikerall, Ciclopoli, Skilarence, Aczone, Decoderm, Cordran Tape, Azelex, Klisyri, Tazorac, Seysara, Veltin, Almax, Ebastel, Sativex, Crestor, and Efficib/Tesavel. Almirall, S.A. has collaboration and partnership agreements with Tyris Therapeutics, BIOMAP, the University of Dundee, Kaken Pharmaceutical Co Ltd., Ichnos Sciences Inc., the University Carlos III Madrid and MEDINA Foundation, 23andMe, Inc., HitGen Ltd., WuXi Biologics, Eli Lilly and Company, and Athenex, Inc. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.
LBTSF Financial Timeline
Browse a chronological timeline of Almirall, S.A. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 10 Nov 2025
Earnings released on 25 Jul 2025
EPS came in at $0.03 , while revenue for the quarter reached $323.04M , beating expectations by +23.86%.
Dividend declared on 15 May 2025
A dividend of $0.21 per share was announced, adjusted to $0.21. The dividend was paid on 4 Jun 2025.
Earnings released on 12 May 2025
EPS came in at $0.11 , while revenue for the quarter reached $313.64M .
Earnings released on 24 Feb 2025
EPS came in at $0.01 , while revenue for the quarter reached $267.28M , beating expectations by +7.13%.
Earnings released on 11 Nov 2024
EPS came in at -$0.04 , while revenue for the quarter reached $252.67M .
Earnings released on 22 Jul 2024
EPS came in at $0.04 , while revenue for the quarter reached $267.11M , missing expectations by -49.77%.
Dividend declared on 17 May 2024
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 5 Jun 2024.
Earnings released on 13 May 2024
EPS came in at $0.04 , while revenue for the quarter reached $267.28M .
Earnings released on 19 Feb 2024
EPS came in at -$0.27 , while revenue for the quarter reached $471.20M .
Earnings released on 9 Jan 2024
EPS came in at $0.02 , while revenue for the quarter reached $220.74M .
Earnings released on 30 Jun 2023
EPS came in at $0.03 , while revenue for the quarter reached $256.07M .
Dividend declared on 12 May 2023
A dividend of $0.20 per share was announced, adjusted to $0.20. The dividend was paid on 31 May 2023.
Earnings released on 31 Mar 2023
EPS came in at $0.05 , while revenue for the quarter reached $252.78M , missing expectations by -49.60%.
Earnings released on 20 Feb 2023
EPS came in at -$0.14 falling short of the estimated $0.08 by -271.01%, while revenue for the quarter reached $459.53M .
Earnings released on 10 Nov 2022
EPS came in at -$0.09 , while revenue for the quarter reached $195.92M .
Earnings released on 25 Jul 2022
EPS came in at $0.04 falling short of the estimated $0.05 by -20.00%, while revenue for the quarter reached $228.43M , missing expectations by -50.23%.
Dividend declared on 13 May 2022
A dividend of $0.19 per share was announced, adjusted to $0.19. The dividend was paid on 1 Jun 2022.
Earnings released on 9 May 2022
EPS came in at $0.11 surpassing the estimated $0.06 by +83.33%, while revenue for the quarter reached $253.30M .
Earnings released on 21 Feb 2022
EPS came in at $0.11 surpassing the estimated $0.02 by +369.48%, while revenue for the quarter reached $237.96M .
Earnings released on 15 Nov 2021
EPS came in at $0.01 falling short of the estimated $0.07 by -85.71%, while revenue for the quarter reached $222.16M .
Earnings released on 26 Jul 2021
EPS came in at $0.08 falling short of the estimated $0.10 by -20.00%, while revenue for the quarter reached $243.57M , missing expectations by -51.53%.
Dividend declared on 14 May 2021
A dividend of $0.22 per share was announced, adjusted to $0.22. The dividend was paid on 2 Jun 2021.
Earnings released on 10 May 2021
EPS came in at $0.23 surpassing the estimated $0.11 by +109.09%, while revenue for the quarter reached $259.47M .
Earnings released on 22 Feb 2021
EPS came in at $0.10 matching the estimated $0.10, while revenue for the quarter reached $1.23B .
Earnings released on 9 Nov 2020
EPS came in at $0.09 surpassing the estimated $0.06 by +50.00%, while revenue for the quarter reached $220.49M .
Dividend declared on 14 Sept 2020
A dividend of $0.24 per share was announced, adjusted to $0.24. The dividend was paid on 1 Oct 2020.
Stock split effective on 14 Sept 2020
Shares were split 47 : 46 , changing the number of shares outstanding and the price per share accordingly.
LBTSF Stock Performance
Access detailed LBTSF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.